The Mesothelioma Center News - Page 2
More Mesothelioma Cancer Centers Using Tumor Treating Fields
- by Sean Marchese
- Treatment & Doctors
- Jul 21, 2020
Tumor Treating Fields is one of the newest treatments on the market for pleural mesothelioma cancer patients with metastatic disease. The device is also available to patients with locally…
Read More
EPA Leaving Libby After Massive Asbestos Cleanup
- by Tim Povtak
- Asbestos Exposure & Bans
- Jul 15, 2020
Mike Cirian came to Libby, Montana, in 2005 to lead the largest asbestos cleanup project in American history, a decontamination effort of unprecedented proportion. He never left. Cirian…
Read More
Nonprofits Call for Worldwide Halt of J&J Baby Powder Sales
- by Tim Povtak
- Asbestos Exposure & Bans
- Jul 13, 2020
National advocacy group Black Women for Wellness joined more than 170 other nonprofits from 51 countries last week in demanding that Johnson & Johnson stop the worldwide distribution of…
Read More
NCI Studying New Mesothelioma Immunotherapy Combination
- by Tim Povtak
- Research & Clinical Trials
- Jul 8, 2020
Patients with mesothelioma are being recruited by the National Cancer Institute for a phase II clinical trial using a novel immunotoxin prior to pembrolizumab, a combination that has…
Read More
Rise in Talc Cases Reshapes Traditional Asbestos Litigation
- by Tim Povtak
- Legislation & Litigation
- Jul 7, 2020
A recent rise in litigation linking cosmetic talc with mesothelioma and lung cancer will continue throughout 2020, despite companies abandoning the product in the hope of avoiding costly verdicts.
Read More
Cryoablation Study for Mesothelioma Opening at UCLA
- by Tim Povtak
- Research & Clinical Trials
- Jul 1, 2020
Researchers at UCLA Jonsson Comprehensive Cancer Center will soon begin studying the pre-surgery use of cryoablation as a potential early adjuvant therapy for patients with pleural mesothelioma. The…
Read More
Johnson & Johnson Talc-Asbestos Verdict Upheld, Award Cut
- by Tim Povtak
- Asbestos Exposure & Bans
- Jun 25, 2020
The Missouri Court of Appeals upheld a landmark jury verdict that said long-term use of Johnson & Johnson’s talc products, possibly contaminated with asbestos fibers, had caused ovarian cancer…
Read More
Tazemetostat Shows Promise for Pleural Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- Jun 24, 2020
Five different research groups at the American Society of Clinical Oncology annual meeting last month made presentations on the effectiveness of tazemetostat, a novel protein inhibitor, in fighting various cancers.
Read More
Mesothelioma Chemoperfusion Trial Shows Impressive Results
- by Tim Povtak
- Research & Clinical Trials
- Jun 22, 2020
Study statistics show the benefits of the novel transarterial chemoperfusion treatment being used successfully at the Moffitt Cancer Center in Tampa for patients with relapsed pleural mesothelioma. Russell Lamkins…
Read More
FDA Approves Keytruda for Certain Mesothelioma Patients
- by Tim Povtak
- Treatment & Doctors
- Jun 17, 2020
Patients with pleural mesothelioma cancer may have another treatment option after the U.S. Food and Drug Administration approved the use of pembrolizumab for certain metastatic tumors this week. Pembrolizumab,…
Read More
